{"entity":{"id":"nct06963840","kind":"trial","name":"Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome","aka":[],"tldr":"A phase 2 trial of an investigational treatment in ovarian cancer, run by Wellizen Australia, active and no longer recruiting.","summary":"Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome is a phase 2 interventional study registered as NCT06963840 by Wellizen Australia, with 16 participants enrolled, started 2025-05-09 and due to reach its primary completion in 2025-08.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06963840","url":"https://clinicaltrials.gov/study/NCT06963840"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06963840","phase":"2","setting":"Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome","sponsor":"Wellizen Australia","enrolled":16,"outcomes":[]},"route":"/trials/nct06963840/","neighbours":{"cancer":[{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}]}}